An ISPOR study compared data from 14,284 participants in 25 different oncology trials and found the compliance rate for in-home or decentralized clinical trials in which patients self-reported was 83.9%, while the compliance rate for site-based trials was 86.3%. This nominal difference indicates patient compliance in hybrid or virtual clinical trials is almost the same as compliance in site-based trials — quite the opposite of what the research industry feared when these trial models became more common during the COVID-19 pandemic.
While there are several possible reasons for these similarities in compliance, perhaps the most compelling is patient centricity in that hybrid and virtual trials are designed to be more convenient for and easier on the patient, which makes the patient more committed to the trial and more likely to remain compliant.
This is just another example of why patient centricity is essential for successful research.
Patient-Centric Trials Are Successful Trials
A patient-centric approach to clinical research is all about making the patient’s needs a priority, whether that means supporting the patient-physician relationship or bringing the study to the patient in their home or community.
Patient centricity isn’t just better for the patients, it’s also better for the entire trial process. Take community-based research as an example. Community-based research, when trials are based in healthcare practices that have deeply rooted relationships with the local population, is inherently patient-centric as patients don’t have to leave their comfortable neighborhoods or even interact with providers beyond their trusted physicians. Community-based research dramatically increases trial diversity and expands participation in traditionally underrepresented populations, both of which benefit all study stakeholders.
Engaging with patients through their trusted physicians, a patient-centric approach to clinical trial enrollment, has also been shown to accelerate trial enrollment to keep studies on time and on budget. Finally, as noted above, enabling even some remote participation reduces the study burden on patients, increasing enrollment, engagement, and retention without sacrificing compliance. Also, if run efficiently, hybrid and virtual trials can also reduce the research staff’s burden and maximize the site’s potential.
Only Elligo Enables Hybrid and Virtual Trials That Benefit All Stakeholders
At Elligo Health Research, we believe the connection between patients and their trusted providers is essential to patient-centric, successful research. We’ve built the Elligo Research Network, our clinical trials network, on this belief, offering site-supporting services and solutions that preserve the patient-physician relationship, increase site revenue, and bring more research as care options to patients.
From the coordination of operational and administrative activities and use of an extensive technology platform to a pipeline of exclusive trials tailored to research interests and patients’ needs, our flexible support capabilities enable patient-centric trials in any capacity, from site-based to hybrid and virtual.
Join the Elligo Research Network
Whether your practice is running on-site, virtual, or hybrid models, let the Elligo Research Network take care of the details so you can run profitable trials that focus on what matters most: your patients.
Join the Elligo Research Network today to build your pipeline of high-interest trials, increase your revenue, and advance the development of new medicines and therapies while providing patient-centric research as care.